Mystery Surrounds Second Samsung Bioepis Avastin Biosimilar
Onbevzi Recommendation Follows Aybintio Approval In August
Samsung Bioepis is lining up two biosimilar bevacizumab products in the EU, after the EMA’s CHMP recommended the company’s Onbevzi product months after approval for Aybintio.
